Influence of taurine on cardiac remodeling induced by tobacco smoke exposure

Cellular Physiology and Biochemistry

Volumn 27, Issue 3-4, 2011, Pages 291-298

  Denipote, Fabiana ^a   Ardisson, Lidiane P ^a   Azevedo, Paula S ^a   Minicucci, Marcos F ^a   Lima Leopoldo, Ana P ^a   Chiuso Minicucci, Fernanda ^a   Polegato, Bertha F ^a   Matsubara, Beatriz B ^a   Matsubara, Luiz S ^a   Novelli, Ethel ^a   Paiva, Sergio A R ^a   Zornoff, Leonardo A M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Heart failure; Smoking; Ventricular function

Indexed keywords

GAMMA INTERFERON; LACTATE DEHYDROGENASE; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PHOSPHOLAMBAN; TAURINE; TOBACCO SMOKE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SMOKING; TREATMENT DURATION;

NICOTIANA TABACUM; RATTUS;

EID: 79953798560     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000327955     Document Type: Article

References (38)

1. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81:1161-1172. (Pubitemid 20119612)
2. Cohn JN, Ferrari R, Sharpe N: Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000;35:569-582. (Pubitemid 30167013)
3. Zornoff LAM, Paiva SAR, Duarte DR, Spadaro J: Ventricular remodeling after myocardial infarction: concepts and clinical implications. Arq Bras Cardiol 2009;92:150-164.
4. Birdsall TB: Therapeutic applications of taurine. Alt Med Rev 1998;3:128-36.
5. Schuller-Levis G, Park E: Taurine: new implications for an old amino acid. FEMS Microbiol Lett 2003;226:195-202. (Pubitemid 38444940)
6. Shi YR, Bu DF, Qi YF, Gao L, Jiang HF, Pang YZ, Tang CS, Du JB: Dysfunction of myocardial taurine transport and effect of taurine supplement in rats with isoproterenol-induced myocardial injury. Acta Pharmacol Sin 2002;23:910-918.
7. Lake N: Loss of cardiac myofi brils: mechanism of contractile deficits induced by taurine deficiency. Am J Physiol 1993;264:1323-1326.
8. Lake N, Roode MD, Nattel S: Effects of taurine depletion on rat cardiac electrophysiology: in vivo and in vitro studies. Life Sci 1987;40:997-1005. (Pubitemid 17016800)
9. Jeejeebhoy F, Keith M, Freeman M, Barr A, Mccall M, Kurian R, Mazer D, Errett L: Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. Am Heart J 2005;143:1092-1100.
10. Lourenço R, Camilo ME: Taurine: a conditionally essential amino acid in humans? An overwiew in health and disease. Nutr Hosp 2002;17:262-270. (Pubitemid 44616128)
11. Kramer JH, Chovan JP, Schaffer SW: The effect of taurine on calcium paradox and ischemic heart failure. Am J Physiol 1981;240:238-246.
12. Abe M, Shibata K, Matsuda T, Furukawa T: Inhibition of hypertension and salt intake by oral taurine treatment in hypertensive rats. Hypertension 1987;10:383-389. (Pubitemid 17160037)
13. Colivicchi MA, Raimondi L, Bianchi L, Tipton KF, Pirisino R, Della Corte L: Taurine prevents streptozotocin impairment of hormone-stimulated glucose uptake in rat adipocytes. Eur J Pharmacol 2004;497:209-215. (Pubitemid 38891878)
14. Paiva SA, Zornoff LA, Okoshi MP, Okoshi K, Cicogna AC, Campana AO: Behavior of cardiac variables in animals exposed to cigarette smoke. Arq Bras Cardiol 2003;81:221-228. (Pubitemid 37237820)
15. Castardeli E, Paiva SA, Matsubara BB, Matsubara LS, Minicucci MF, Azevedo PS, Campana AO, Zornoff LAM: Chronic cigarette smoke exposure results in cardiac remodeling and impaired ventricular function in rats. Arq Bras Cardiol 2005;84:320-324. (Pubitemid 40695340)
16. Zornoff LA, Matsubara LS, Matsubara BB, Okoshi MP, Okoshi K, Dal Pai-Silva M, Carvalho RF, Cicogna AC, Padovani CR, Novelli EL, Novo R, Campana AO, Paiva SA: Beta-carotene supplementation attenuates cardiac remodeling induced by one-month tobacco-smoke exposure in rats. Toxicol Sci 2006;90:259-266. (Pubitemid 43264746)
17. Castardeli E, Duarte DR, Minicucci MF, Azevedo PS, Matsubara BB, Matsubara LS, Campana AO, Paiva SA, Zornoff LA: Exposure time and ventricular remodeling induced by tobacco smoke exposure in rats. Med Sci Monit 2008;14:62-66.
18. Castardeli E, Duarte DR, Minicucci MF, Azevedo PS, Matsubara BB, Matsubara LS, Campana AO, Paiva SA, Zornoff LA: Tobacco smoke-induced left ventricular remodeling is not associated with metalloproteinase-2 or -9 activation. Eur J Heart Fail 2007;9:1081-1085. (Pubitemid 47633318)
19. Houdi AA, Dowell RT, Diana JN: Cardiovascular responses to cigarette smoke exposure in restrained conscious rats. J Pharmacol Exp Ther 1995;275:646-653. (Pubitemid 26023609)
20. Gu L, Pandey V, Geenen DL, Chowdhury SAK, Piano MR: Cigarette smoke-induced left ventricular remodeling is associated with activation of mitogen-activated protein kinases. Eur J Heart Fail 2008;10:1057-1064.
21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463. (Pubitemid 41821197)
22. Minicucci MF, Azevedo PS, Oliveira SA Jr, Martinez PF, Chiuso-Minicucci F, Polegato BF, Justulin LA Jr, Matsubara LS, Matsubara BB, Paiva SA, Zornoff LA: Tissue vitamin A insufficiency results in adverse ventricular remodeling after experimental myocardial infarction. Cell Physiol Biochem 2010;26:523-30.
23. Azevedo PS, Minicucci MF, Chiuso-Minicucci F, Justulin LA Jr, Matsubara LS, Matsubara BB, Novelli E, Seiva F, Ebaid G, Campana AO, Zornoff LA, Paiva SA: Ventricular remodeling induced by tissue vitamin a deficiency in rats. Cell Physiol Biochem 2010;26:395-402.
24. Bass A, Brdiczka D, Eyer P, Hofer S, Pette D: Metabolic differentiation of distinct muscle types at the level of enzymatic organization. Eur J Biochem 1969;10:198-206.
25. Vescovo G, Ceconi C, Bernocchi P, Ferrari R, Carraro U, Ambrosio GB, Libera LD: Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. Cardiovasc Res 1998;39:233-241. (Pubitemid 28322393)
26. Minicucci MF, Azevedo PS, Paiva SA, Zornoff LA: Cardiovascular remodeling induced by passive smoking. Inflamm Allergy Drug Targets 2009;8:334-339.
27. Gupta MP: Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol 2007;43:388-403.
28. Mann DL: Tumor necrosis factor-induced signal transduction and left ventricular remodelling. J Card Fail 2002;8:S379-384.
29. Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N: Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 2010;15:543-62.
30. Ambrose JA, Barua RS: The pathophysiology of cigarette smoking and cardiovascular disease. J Am Coll Cardiol 2004;43:1731-1737. (Pubitemid 38622506)
31. Janicki JS, Brower GL: The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail 2002;8:S319-325.
32. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium. Fibrosis and rennin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
33. Janicki JS, Matsubara BB: Myocardial collagen and left ventricular diastolic dysfunction; in Gaash W, LeWinter M, (eds): Left Ventricular Diastolic Dysfunction and Heart Failure. Philadelphia, Lea & Febiger, 1994, pp 125-140.
34. Van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ: Metabolic remodeling of the heart: beneficial or detrimental? Cardiovasc Res 2009;81:420-428.
35. Militante JD, Lombardini JB, Schaffer SW: The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus. Cardiovasc Res 2000;46:393-402. (Pubitemid 30319325)
36. Mudd JO, Kass DA: Tackling heart failure in the twenty-first centure. Nature 2008;451:919-928. (Pubitemid 351301747)
37. Bers DM: Altered cardiac myocyte Ca regulation in heart failure. Physiology 2006;21:380-387.
38. Zornoff LA, Matsubara BB, Matsubara LS, Azevedo PS, Minicucci MF, Campana AO, Paiva SA: Beta-carotene supplementation results in adverse ventricular remodeling after acute myocardial infarction. Nutrition 2006;22:146-151. (Pubitemid 43188804)